Ole Rossvoll

Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound : relation to left ventricular diastolic pressures

OBJECTIVES This study was conducted to investigate whether pulmonary venous flow variables measured by transthoracic Doppler ultrasound can help identify patients with elevated left ventricular end-diastolic or filling pressures, or both. BACKGROUND A widened left atrial pressure A wave occurs when left ventricular end-diastolic pressure is increased. Increased duration of pulmonary venous flow reversal at atrial systole might therefore be a marker for elevated end-diastolic pressure. Decreased systolic pulmonary venous flow is shown to be related to increased left ventricular filling pressure in studies using transesophageal Doppler echocardiography. METHODS Left ventricular pressures at late diastole were measured by fluid-filled catheters in 50 consecutive patients undergoing diagnostic cardiac catheterization. Pulmonary venous and mitral flow velocities were recorded by transthoracic pulsed Doppler ultrasound. RESULTS Adequate recordings were obtained in 45 patients. Pulmonary venous flow reversal exceeding the duration of the mitral A wave predicted left ventricular end-diastolic pressure > 15 mm Hg with a sensitivity of 0.85 and a specificity of 0.79. This difference in flow duration correlated well with the increase in ventricular pressure (r = 0.70, p < 0.001) at atrial systole and the end-diastolic pressure (r = 0.68, p < 0.001). The systolic fraction of pulmonary venous flow was markedly decreased (< 0.4) in all patients with a pre-A pressure (left ventricular pressure before atrial systole) > 18 mm Hg. CONCLUSIONS Pulmonary venous flow reversal exceeding the duration of the mitral A wave indicates an exaggerated increase in left ventricular late diastolic pressure. Pulmonary venous systolic fraction < 0.4 suggests markedly increased ventricular filling pressure.

The Velocity Distribution in the Aortic Anulus in Normal Subjects: A Quantitative Analysis of Two-dimensional Doppler Flow Maps

The velocity distribution in the aortic anulus is commonly assumed to be uniform. A skewed velocity profile may have consequences for the accuracy of volume flow estimates by the Doppler echocardiographic technique. To assess this issue, the velocity distribution in the aortic anulus in 12 normal subjects was studied by computer analysis of digital velocity data from two-dimensional Doppler ultrasound flow maps. The velocity profiles in the aortic anulus were found to be flat but slightly skewed, with the highest velocities toward the septum. There was little interindividual variation. Our findings imply that the centerline velocity is the best estimate for the spatial mean velocity at the aortic anulus in normal subjects. The importance of this finding in patients is unknown. In normal subjects, the results suggest that stroke volume might be overestimated by approximately 15% by Doppler echocardiography if the cross-sectional velocity profile is not accounted for.

Cross sectional early mitral flow velocity profiles from colour Doppler.

Instantaneous cross sectional flow velocity profiles from early mitral flow in 10 healthy men were constructed by time interpolation of the velocity data from each point in sequentially delayed two dimensional digital Doppler ultrasound maps. This interpolation allows correction of the artificially produced skewness of velocities across the flow sector caused by the time taken to scan the flow sector for velocity recording of pulsatile blood flow. These results suggested that early mitral flow studied in an apical four chamber view is variably skewed both at the leaflet tips and at the annulus. The maximum flow velocity overestimated the cross sectional mean velocity at the same time by a factor of 1.2-2.2. Also the maximum time velocity integral overestimated the cross sectional mean time velocity integral to the same extent. This cross sectional skew must be taken into account when calculation of blood flow is based on recordings with pulsed wave Doppler ultrasound from a single sample volume.

Aerobic Interval Training Reduces the Burden of Atrial Fibrillation in the Short Term A Randomized Trial

Background— Exercise training is an effective treatment for important atrial fibrillation (AF) comorbidities. However, a high level of endurance exercise is associated with an increased AF prevalence. We assessed the effects of aerobic interval training (AIT) on time in AF, AF symptoms, cardiovascular health, and quality of life in AF patients. Methods and Results— Fifty-one patients with nonpermanent AF were randomized to AIT (n=26) consisting of four 4-minute intervals at 85% to 95% of peak heart rate 3 times a week for 12 weeks or to a control group (n=25) continuing their regular exercise habits. An implanted loop recorder measured time in AF continuously from 4 weeks before to 4 weeks after the intervention period. Cardiac function, peak oxygen uptake ( O2peak), lipid status, quality of life, and AF symptoms were evaluated before and after the 12-week intervention period. Mean time in AF increased from 10.4% to 14.6% in the control group and was reduced from 8.1% to 4.8% in the exercise group (P=0.001 between groups). AF symptom frequency (P=0.006) and AF symptom severity (P=0.009) were reduced after AIT. AIT improved O2peak, left atrial and ventricular ejection fraction, quality-of-life measures of general health and vitality, and lipid values compared with the control group. There was a trend toward fewer cardioversions and hospital admissions after AIT. Conclusions— AIT for 12 weeks reduces the time in AF in patients with nonpermanent AF. This is followed by a significant improvement in AF symptoms, O2peak, left atrial and ventricular function, lipid levels, and QoL. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT01325675.

Curative ablation for atrial fibrillation: a systematic review.

Objective. To perform a systematic review of randomized controlled trials (RCTs) on catheter ablation for atrial fibrillation (AF). Background. Radiofrequency catheter (RF)-ablation around pulmonary vein ostia and in left atrium may reduce or prevent recurrence of AF, as documented in observational studies and registry reports; however, few RCTs are available. Methods. Using relevant search phrases, Cochrane Library, MEDLINE and EMBASE were searched for RCTs, last time in May 2007. Titles and abstracts were screened. When entry criteria were fulfilled, full-text papers were read and graded according to quality and relevance. Results. One thousand and ninety four abstracts were evaluated, and five RCTs included (578 randomized patients). The studies had moderate quality and relevance, but the results were consistent: ablation is better than drug treatment in preventing AF recurrence; the relative risk (95% CI)) one year after ablation ranged from 0.20 (0.08–0.51) to 0.62 (0.39–0.99). Conclusions. Results from observational and registry studies are confirmed: RF-ablation reduces recurrence rate of AF, and can be done with few serious complications. Limitations are few patients >70 years, and only one year follow-up.

Instantaneous cross-sectional flow velocity profiles: a comparative study of two ultrasound Doppler methods applied to an in vitro pulsatile flow model.

Two methods based on different techniques for construction of cross-sectional flow velocity profiles from Doppler ultrasound signals were compared: an intraluminal method using pulsed-wave Doppler echocardiography and an extraluminal method using two-dimensional (color) Doppler ultrasound. The methods were applied to an in vitro pulsatile flow model. With the intraluminal method, pulsed Doppler recordings obtained throughout several flow pulses at different positions across a tube were digitized, and cross-sectional flow velocity profiles were obtained by matching the onset of flow velocity at the various positions. With the extraluminal method, cross-sectional flow velocity profiles were obtained by time interpolation between the digital flow velocity data obtained from several flow velocity maps. The first flow velocity map was recorded at onset of flow and the following maps were incrementally delayed with 20 msec from one flow pulse to the next. The time lag caused by the time needed to update each of the flow velocity maps was compensated for by time interpolation between the sequentially recorded flow velocity maps. The cross-sectional flow velocity profiles obtained with the two methods were compared at identical positions within the tube model at equal flow settings and throughout the pulsatile flow periods. At three different flow settings with peak flow velocity of 0.3, 0.5, and 0.7 m/sec, the difference (mean +/- SD) between the obtained velocities were 0.01 +/- 0.04, -0.01 +/- 0.05, and -0.03 +/- 0.07 m/sec, respectively. The findings suggest that cross-sectional flow velocity profiles from pulsatile flow velocity recordings can be obtained equally well with both methods.

Cross-sectional Left Ventricular Outflow Tract Velocities Before and After Aortic Valve Replacement: A Comparative Study With Two-dimensional Doppler Ultrasound

To assess whether aortic valve replacement (AVR) results in changes in the flow velocity distribution in the left ventricular outflow tract (LVOT), 10 patients undergoing AVR for aortic stenosis were studied. By extracting velocity information from color flow maps as digital data, instantaneous cross-sectional velocity profiles were constructed. Velocity profiles obtained 1 to 3 days before AVR were compared with recordings made 3 months later. The LVOT velocity profiles were variably skewed both before and after surgery, and no systematic or uniform changes could be detected after AVR. The highest velocities were most often localized in the region from the center of the outflow tract diameter toward the septum both before and after surgery. At the time of peak flow the ratio of the maximum to the cross-sectional mean velocity was 1.38 +/- 0.13 before and 1.39 +/- 0.08 after AVR (NS), and the ratio of the maximum to the mean velocity time integral was 1.47 +/- 0.10 before and 1.56 +/- 0.10 after (NS). We conclude that AVR in patients with aortic stenosis does not result in a change in LVOT velocity profiles that will influence stroke volume estimates with the Doppler technique.

Validity of an early postoperative baseline Doppler recording after aortic valve replacement

In 131 patients undergoing aortic valve replacement (53 bioprostheses, 78 mechanical), the pressure decrease across the prosthesis was recorded with Doppler ultrasound at a baseline study early postoperatively (mean 11 +/- 5 days) and compared with a repeat measurement 3 to 5 months later. At baseline the hemodynamic state was markedly different, with increased heart rate (89 +/- 14 vs. 74 +/- 13 beats/min, p less than 0.001) and decreased left ventricular ejection time index (367 +/- 21 vs 390 +/- 22, p less than 0.001). A minor and clinically insignificant decrease in pressure decrease with time was found. The 95% confidence interval for the difference was 0.2 to 3.0 and 0.2 to 1.7 mm Hg for the peak and the mean pressure decrease, respectively. The change in pressure decrease was statistically significant for bioprostheses (mean 16 +/- 5 vs 14 +/- 4 mm Hg, p less than 0.01) and smaller (less than or equal to 23 mm) valves (mean 17 +/- 4 vs 15 +/- 4 mm Hg, p less than 0.01), whereas no significant changes were found for mechanical valves or valves of a larger size. The change in mean pressure decrease from baseline to the second examination was within +/- 5 mm Hg for 82% of patients. It is concluded that despite a different hemodynamic state in the early postoperative period, the pressure decrease across aortic valve prostheses obtained at this time can be used as a reference for later comparison.

Cross-sectional early mitral flow-velocity profiles from color Doppler in patients with mitral valve disease.

BackgroundCross-sectional flow-velocity profiles from early mitral flow in 20 patients (10 with mitral regurgitation and 10 with mitral stenosis) were constructed from the velocity data from each point in sequentially delayed two-dimensional digital Doppler ultrasound maps. Methods and ResultsThe data suggested that the early mitral flow studied in an apical four-chamber view was variably skewed in both patient groups. The maximum flow velocity overestimated the cross-sectional mean velocity at the same time by a factor of 1.12–1.86. The maximum time-velocity integral was 1.13ndash;1.77ndash;fold greater than the cross-sectional mean time-velocity integral. In patients with mitral regurgitation, the cross-sectional flow-velocity profile appeared to be most skewed at the level of the mitral leaflet tips. The level of the mitral annulus appeared to give the most homogenous flow-velocity distribution in both patient groups. ConclusionsWhen calculations of volume flow are based on pulsed Doppler ultrasound recordings with a single sample volume, the possibility of a skewed flow-velocity profile must be taken into account.

Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA)

The European Snapshot Survey on Procedural Routines in Atrial Fibrillation Ablation (ESS-PRAFA) is a prospective, multicentre snapshot survey of patients undergoing atrial fibrillation (AF) ablation, conducted to collect patient-based data on current clinical practices in AF ablation in context of the latest AF Guidelines and contemporary oral anticoagulant therapies. The EP Research Network Centres were asked to prospectively enrol consecutive patients during a 6-week period (September/October 2014). Data were collected via the web-based case report form. We present the results pertinent to the use of antithrombotic therapies. Thirteen countries prospectively enrolled 455 eligible consecutive patients [mean age 59 ± 10.8 years, 131 (28.8%) females]. The mean CHA2DS2-VASc score was 1.12 ± 1.06 [137 patients (30.1%) had a score of ≥2]. Before ablation, 443 patients (97.4%) were on anticoagulant therapy [143 (31.4%) on non-vitamin K antagonist oral anticoagulants (NOACs) and 264 (58.0%) on vitamin K antagonists (VKAs)]. Of the latter, 79.7% underwent ablation without VKA interruption, whilst a variety of strategies were used in patients taking NOAC. After ablation, most patients (89.3%) continued the same anticoagulant as before, and 2 (0.4%) were not prescribed any anticoagulation. At discharge, 280 patients (62.2%) were advised oral anticoagulation for a limited period of mean 3.8 ± 2.2 months. On multivariate analysis, CHA2DS2-VASc, AF duration, prior VKA use, and estimated AF ablation success were significantly associated with the decision on short-term anticoagulation. Our results show the increasing use of NOAC in patients undergoing AF ablation and emphasize the need for more information to guide the periprocedural use of both NOACs and VKAs in real-world setting.